Even though political activism tends to be the hallmark of the International AIDS Conferences, the 2004 biennial meeting in Bangkok – the best attended meeting in the history of the conclave – was notable for studies which described tong-term adherence to highly active antiretroviral therapy (HAART).
A striking study found that even highly experienced patients who had reached the end of the road with oral HAART were able to benefit from injectable enfurvitide, the first of the fusion inhibitors.